US 8765932
Compositions and methods for inhibiting expression of XBP-1 gene
granted A61PA61P35/00
Quick answer
US patent 8765932 (Compositions and methods for inhibiting expression of XBP-1 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P35/00